Olivia Poupardin-Olivier

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignees: Laboratoires Fournier Sa, Bioprojet, Laboratories Fournier S.a.. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivia Poupardin-Olivier. Retrieved from https://idiyas.com/inventor/olivia-poupardin-olivier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Varios et Chaignot, FR (2010)
Varois et Chaignot, FR (2009 - 2013)

Company Filing History:

5 out of 20

Laboratoires Fournier Sa

Laboratories Fournier S.a.

patents

Years Active: 2009-2013

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8575210 - Use of indole derivatives as NURR-1 activators for treating parkinson's disease (2013-11-05),

2. 8546385 - Benzoic pyrrolopyridine derivatives (2013-10-01),

3. 8436040 - Method of treating conditions involving PPAR-receptors with indole compounds (2013-05-07),

4. 8076329 - Histamine H3-receptor ligands and their therapeutic applications (2011-12-13),

5. 8017646 - [object Object] (2011-09-13),

6. 7795297 - Indole compounds, method of preparing them and uses thereof (2010-09-14),

7. 7728002 - Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of conditions involving such receptors (2010-06-01),

8. 7557122 - Pyrrolopyridine compounds, method of making them and uses thereof (2009-07-07),

Title: **Olivia Poupardin-Olivier: Innovator in Parkinson's Disease Research**

Introduction

Olivia Poupardin-Olivier is a distinguished inventor based in Varois et Chaignot, France. With a total of eight patents to her name, she has made significant contributions to the field of medicinal chemistry, particularly focusing on therapies for neurodegenerative diseases such as Parkinson's disease.

Latest Patents

Among her notable inventions, Olivia has developed a groundbreaking patent titled "Use of indole derivatives as NURR-1 activators for treating Parkinson's disease." This invention details a compound derived from indole that holds therapeutic potential in activating the NURR-1 nuclear receptor, which is essential in the treatment of Parkinson's disease. Another significant patent is for "Benzoic pyrrolopyridine derivatives," which comprises compounds that modulate the NURR-1 nuclear receptors, further showcasing her innovative approach to developing therapeutics.

Career Highlights

Olivia Poupardin-Olivier has had a remarkable career, marked by her work in prestigious companies such as Laboratoires Fournier and Bioprojet. These experiences have greatly influenced her research and allowed her to develop innovative solutions aimed at alleviating neurodegenerative conditions.

Collaborations

Throughout her career, Olivia has collaborated with notable professionals, including Jean Louis Binet and Pierre Dodey. These partnerships have enriched her research endeavors and contributed to her successful innovations.

Conclusion

Olivia Poupardin-Olivier continues to be a trailblazer in the field of medicinal innovation, with her patents paving the way for new treatments for Parkinson's disease. Her work exemplifies the positive impact that dedicated inventors can have on the world of medicine and patient care.

Profile summary based on public USPTO records.